10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Nov. 16, 2018
| By Sabin Russell / Fred Hutch News Service
Fred Hutch is about to lead a clinical trial offering cord blood transplants to blood cancer patients who also have HIV. The tranplants will carry a genetic trait that naturally confers resistance to HIV, so there is a possibility these transplants might also cure their HIV.
Dr. Filippo Milano and colleagues in the Cord Blood Program at Fred Hutch have received funding from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation to support a clinical trial to improve the use of umbilical cord blood as a treatment for leukemia ... and more good news at Fred Hutch.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.